RecruitingNot ApplicableNCT06230367
Sexual Health Advocacy for Guys - a Text Messaging-based HIV Prevention Program for Guys Who Are Into Guys
Harnessing the Power of Text Messaging to Reduce HIV Incidence in Adolescent Males Across the United States
Sponsor
Center for Innovative Public Health Research
Enrollment
5,000 participants
Start Date
Jan 15, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
SHAG is a text messaging-based HIV prevention program designed for cisgender sexual minority boys and men 13-20 years of age across the United States. Investigators will test it against a control group that receives messages about healthy lifestyle.
Eligibility
Sex: MALEMin Age: 13 YearsMax Age: 22 Years
Inclusion Criteria10
- have been assigned male sex at birth and currently have a cisgender identity;
- be aged 13-22 years old;
- have had anal sex in the past 12 months;
- be English-speaking;
- exclusively own a cell phone with an unlimited text messaging plan and intend to have the same cell phone number for the next 6 months;
- have Internet access to complete online surveys;
- provide informed assent for those under 18, and consent for those 18 years of age and older, including a capacity to consent and a positive self-safety assessment;
- Willing to take an OraQuick home test to confirm HIV negativity for youth who are 19-20 years of age or 18 years old and graduated high school. If they agree to do the test but do not upload a photo of their result, they will be eligible if they self-report a negative sero-status. Youth 18 years old who have not graduated high school, and 13-17 years of age will be asked to take a home test. If they determine that they cannot do so safely, they will be allowed to self-report their sero-status; and
- not currently enrolled in another HIV prevention program; or
- know anyone already enrolled in the RCT.
Exclusion Criteria1
- Being HIV positive
Interventions
BEHAVIORALSexual health advocacy for guys
5 month HIV prevention program delivered via text messaging
BEHAVIORALHealthy lifestyle control
5 month control group program delivered via text messaging
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06230367
Related Trials
A Randomized Clinical Trial to Evaluate Solutions for the Management of Virologic Failure on TLD in Sub-Saharan Africa
NCT053737583 locations
First Time in Human Study of Long Acting VH4524184 Formulations
NCT063105512 locations
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
NCT0720254662 locations
Development and Evaluation of a Virtual Reality Tool for At-Risk Trauma-Exposed Young People
NCT058160831 location
A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1
NCT0669480589 locations